drugset / Trial / NCT07024693
DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the pharmacodynamics, safety, and tolerability of DT-168 Ophthalmic Solution in pre-keratoplasty patients with Fuchs endothelial corneal dystrophy.
Timeline
- Start
- 2025-07-30
- Primary completion
- 2026-09
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DT-168 | Unknown | — | — |